A Reduced-Intensity Conditioning Regimen for Patients with Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation

Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative option for progressive marrow failure, myelodysplastic syndrome, or leukemia associated with dyskeratosis congenita (DC). HSCT for DC is limited by a high incidence of treatment-related mortality, thought to be related to...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Biol Blood Marrow Transplant
Hlavní autoři: Nelson, Adam S., Marsh, Rebecca A., Myers, Kasiani C., Davies, Stella M., Jodele, Sonata, O’Brien, Tracey A., Mehta, Parinda A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4826289/
https://ncbi.nlm.nih.gov/pubmed/26845033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2016.01.026
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky